Four WIN compounds with anti-picornavirus activities were tested for their ability to stabilize human rhinovirus serotype 2 (HRV-2) against low pH-induced conformational changes in vitro, as determined by specific immunoprecipitation. These results were compared to the minimal inhibitory concentration (MIC) as measured in a plaque reduction assay. A direct relationship was observed between the concentration of the compound that prevented the low pH-induced conformational changes and the MIC, indicating that stabilization is an important element in the mode of action of these drugs against HRV-2.
KorantB. D.,
Lonberg-HolmK.,
NobleJ.,
StasnyJ. T.1972; Naturally occurring and artificially produced components of three rhinoviruses. Virology 48:71–86
KowalskiH.,
Maurer-FogyI.,
VriendG.,
CasariG.,
BeyerA.,
BlaasD.1989; Trypsin sensitivity of several human rhinovirus serotypes in their low pH induced conformation. Virology 171:611–614
Lonberg-HolmK.,
WhiteleyN. M.1976; Physical requirements for early interaction of poliovirus and human rhinovirus with HeLa cells. Journal of Virology 19:857–870
MadshusI. G.,
OlsnesS.,
SandvigK.1984a; Different pH requirements for entry of two picornaviruses, human rhinovirus 2 and murine encephalomyocarditis virus. Virology 139:346–357
PevearD. C.,
FancherM. J.,
FelockP. J.,
RossmannM. G.,
MillerM. S.,
DianaG.,
TreasurywalaA. M.,
McKinlayM. A.,
DutkoF. J.1989; Conformational change in the floor of the human rhinovirus canyon blocks adsorption to HeLa cell receptors. Journal of Virology 63:2002–2007
RossmannM. G.,
ArnoldE.,
EricksonJ. W.,
FrankenbergerE. A.,
GriffithJ. P.,
HechtH.-J.,
JohnsonJ. E.,
KamerG.,
LuoM.,
MosserA. M.,
RueckertR. R.,
SherryB. A.,
VriendG.1985; Structure of a common cold virus, human rhinovirus 14. Nature, London 317:145–154
SmithT. J.,
KremerJ.,
LuoM.,
VriendG.,
ArnoldE.,
KamerG.,
RossmannM. G.,
McKinlayM. A.,
DianaG. D.,
OttoM. J.1986; The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science 233:1286–1293
WoodsM. G.,
DianaG. D.,
RoggeM. C.,
OttoM. J.,
DutkoF. J.,
McKinlayM. A.1989; In vitro and in vivo activities of WIN54954, a new broad-spectrum anti-picornavirus drug. Antimicrobial Agents and Chemotherapy 33:2069–2074